LoginSign Up
eGenesis

eGenesis

A Cambridge, MA - based startup that uses gene editing tech for xenotransplantation procedures in the medical industry.

All edits

Edits on 29 Sep 2018
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 29 Sep 2018 12:25 am
Edits made to:
Article (+0/-0 images) (+0/-0 videos) (+15/-15 characters)

Article

In August 2018 eGenesis has disclosed $40m in funding by ARCH Venture Partners, Biomatics Capital Partners, Khosla VenturesKhosla Ventures, and Fan Ventures.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 28 Sep 2018 11:04 pm
Edits made to:
Article (+0/-0 images) (+0/-0 videos) (+6/-6 characters)

Article

eGenesis' state goal is to make xenotransplantation a routine medical procedure. The company is a Cambridge, MA-based startup that's using the gene-editing tool CRISPRCRISPR to make pig organs viable for transplants into people.

Carla Faraguna
Carla Faraguna edited on 28 Sep 2018 9:44 pm
Edits made to:
Name
Infobox (+1/-0 properties)
Article (+0/-0 images) (+0/-0 videos) (+676/-11 characters)
People (+4/-0 cells) (+43/-0 characters)
Related Topics (+2/-0 topics)
Topic thumbnail

Egenesis eGenesis

A Cambridge, MA - based startup that uses gene editing tech for xenotransplantation procedures in the medical industry.

Article

Funding

In August 2018 eGenesis Bio has disclosed $40m in funding by ARCH Venture Partners, Biomatics Capital Partners, Khosla Ventures, and Fan Ventures.

eGenesis' state goal is to make xenotransplantation a routine medical procedure. The company is a Cambridge, MA-based startup that's using the gene-editing tool CRISPR to make pig organs viable for transplants into people.

...

The company raised $38 million in March 2017 and is cofounded by Harvard geneticist George Church and 31-year old Luhan Yang. Their research is focusing on removing certain genes in pigs that could cause diseases or organ rejection in humans, making it possible for those pig organs to be transplanted. eGenesis announced in the journal Science that it had produced 37 piglets that had inactivated Porcine Endogenous Retrovirus, or PERV.

People

Name
Role
Related Golden topics

Co-founder

Luhan Yang

Co-founder

Infobox

Related Topics

Edits on 15 Aug 2018
Thomas Shaddox
Thomas Shaddox approved a suggestion from Golden's AI on 15 Aug 2018 6:44 pm
Edits made to:
Article (+0/-0 images) (+0/-0 videos) (+21/-21 characters)

Article

eGenesis Bio has disclosed $40m in funding by ARCH Venture PartnersARCH Venture Partners, Biomatics Capital Partners, Khosla Ventures, and Fan Ventures.

Carla Faraguna
Carla Faraguna edited on 15 Aug 2018 6:05 pm
Carla Faraguna
Carla Faraguna edited on 15 Aug 2018 6:05 pm
Edits made to:
Description (+120/-0 characters)
Article (+0/-0 images) (+0/-0 videos) (+138/-0 characters)
Categories (+1/-0 topics)
Topic thumbnail

eGenesis

A Cambridge, MA - based startup that uses gene editing tech for xenotransplantation procedures in the medical industry.

Article

Funding

eGenesis Bio has disclosed $40m in funding by ARCH Venture Partners, Biomatics Capital Partners, Khosla Ventures, and Fan Ventures.

Categories

Edits on 25 Jul 2018
Melanie Manipula
Melanie Manipula edited on 25 Jul 2018 12:41 am
Edits on 21 Apr 2018
Melanie Manipula
Melanie Manipula edited on 21 Apr 2018 12:01 am
Edits made to:
Thumbnail
Topic thumbnail

eGenesis

A Cambridge, MA - based startup that uses gene editing tech for xenotransplantation procedures in the medical industry.

Melanie Manipula"Initial topic creation"
Melanie Manipula edited on 20 Apr 2018 11:47 pm
Edits made to:
Name
Thumbnail
Description (+0/-0 characters)
Article
Academic papers
People
Further reading
Documentaries, videos and podcasts
Companies
Products
Topic thumbnail

 Egenesis

A Cambridge, MA - based startup that uses gene editing tech for xenotransplantation procedures in the medical industry.

No more activity to show.